Communications
question whether the higher-order structures can be obtained
ex vivo through acid-promoted biomimetic synthesis.
tion), into key intermediates 12 and 13. This process required
five operations, and their critical relative configurations were
established with greater than 20:1 selectivity by either basic
(12) or acidic (13) work-up following formylation.[7] With this
key stereodivergence secured, we then directed our attention
towards stereoselectively adding the linear crotyl chains
needed to obtain the target alkene isomers. Among available
methods, Lewis acid promoted variants appeared the most
appealing since a simple switch in the Lewis acid used could
potentially enable selective access to the respective E- and
Z-isomers.
Given the consistently reported failure of structures of
general architecture 1–3 to afford the dimeric members of the
family, our synthetic approach was predicated on the idea that
an alternate starting material was required if a biomimetic
synthesis was to prove successful. In our past efforts seeking
to achieve the controlled synthesis of members of other
oligomeric natural product families,[4] we have often identi-
fied such unique building blocks by searching for anomalous
structural features within the higher-order members; here, we
wondered if the structure of myrmicarin 663 (6) might provide
the needed design clues since one-third of its architecture is
inconsistent with direct oligomerization of myrmicarin 215-
type monomers. Indeed, retrosynthetic cleavage of its C-7/C-8
and C-20/C-21 bonds suggested a structure of type 9 as a
possible alternate building block.[5] Its cyclodehydration was
anticipated to afford monomers 1–3, while the influence of
both its olefin geometry and C-5 ketone stereochemistry was
hoped capable of setting the critical C-3 ethyl stereocenter
and ultimately leading to 4. Despite the appeal of this idea,
literature precedent regarding the stability of compounds
with structures similar to 9 was discouraging,[2a] and even if
they could be prepared, it was not obvious which combination
of isomers would give rise to the desired product stereo-
chemistry. We thus set out to answer these questions, hoping
to selectively synthesize all four possible diastereomers of
generalized starting material 9.
As shown in Scheme 2, this approach proved successful, as
the exposure of 12 and 13 to the crotylcerium reagent
[8]
prepared from CeCl3 and 2-butenylmagnesium chloride
afforded selective access to the linear E-isomers (6:1 a:g, 8:1
[9]
E/Z), while use of the crotylaluminum reagent from AlCl3
furnished the linear Z-isomers (4:1 a:g, > 15:1 Z/E). Sub-
sequent Dess–Martin oxidation of the resultant diastereo-
meric mixture of diols and separation of the minor branched
isomer through silica gel chromatography afforded rapid and
highly selective access to 14–17 in 26–36% overall yield from
commercial materials. Finally, N-Boc deprotection of each of
these four isomers with TFA in the presence of H2O,[10]
followed by a cold aqueous NaOH quench,[11] afforded
dienamines 18–21 as stable and fully characterizable com-
pounds.[12] This outcome is in stark contrast to previous
studies on myrmicarin 217 (3, Figure 1). Indeed, unlike their
monoenamine counterparts that have been shown to both
spontaneously epimerize at the C-5 position (as noted within
9) and cyclize to myrmicarin 217 (albeit in low yields),[2a] these
compounds are both configurationally stable[13] and do not
undergo spontaneous cyclization in aprotic solvents. When
exposed to protic solvents, however, 18–21 were readily
converted into the monomeric myrmicarin alkaloids 215A (1)
and 215B (2) through Knorr pyrrole condensation. For 18 and
19, simple dissolution in argon-purged MeOH at 238C proved
sufficient, while 20 and 21 required stirring in NaOMe/MeOH
at 508C for 1 h (through presumed epimerization at C-5 prior
to cyclodehydration). Overall, these natural products were
synthesized in ten linear steps from commercial materials in
29% and 31% overall yield, respectively. A similar sequence
also enabled access to myrmicarin 217 (3) as well as myrmi-
carin 237B (see Supporting Information for full details). More
significantly, with 18–21 in hand and the means to arrest or
effect their cyclodehydration through solvent control, explo-
rations into unique biomimetic dimerizations could begin.
Initial efforts commenced by exposing 18–21 to a series of
acidic and aqueous buffers, hoping for a direct, biomimetic
synthesis of myrmicarin 430A (4, Figure 1). Unfortunately,
despite the ease with which 1 and 2 were formed under some
of these conditions, we never observed the formation of
characterizable dimeric materials.[14] Thus, we shifted to
stepwise approaches, hoping to identify a method to stoichio-
metrically protonate dienamines 18–21 and generate their
corresponding extended iminium ions as a prelude to adding
more 18–21 (to serve as nucleophile).[15] As indicated in
Scheme 3, previous work by Movassaghi and Ondrus dem-
onstrated that myrmicarin 215 (2) does not undergo stoichio-
metric protonation to give a stable Z-azafulvenium (22),[3ab]
We began by elaborating compound 10 (Scheme 1),
prepared in one step in 84% yield and 86% ee using a
method developed by Ma et al.[6] (see Supporting Informa-
Scheme 1. Synthesis of key intermediates 12 and 13: a) H2 (1 atm),
Pd/C (10%, 0.05 equiv), Boc2O (1.3 equiv), EtOAc, 238C, 16 h, 84%;
concentrate; DIBAL-H (1.1 equiv), THF, ꢀ788C, 45 min; 08C, 15 min,
98%; b) TBSCl (1.3 equiv), imidazole (2.0 equiv), CH2Cl2, 238C, 12 h,
98%; c) sBuLi (1.8 equiv), TMEDA (2.2 equiv), Et2O, ꢀ78!ꢀ408C,
1 h; DMF (10 equiv), ꢀ78!ꢀ408C, 1.5 h; K2CO3/MeOH or NH4Cl,
90% for 12, 97% for 13; d) CeCl3 (1.5 equiv), EtMgBr (1.5 equiv),
THF, ꢀ40!08C; HCl (2.0 equiv), 3 h, 70% for 12, 89% for 13;
e) TEMPO (0.05 equiv), NCS (1.0 equiv), nBu4NCl (0.1 equiv), NaBr
(1.0 equiv), CH2Cl2, pH 8.6 aqueous buffer, 08C, 1.5 h, 93% for 12,
96% for 13. Boc2O=di-tert-butyldicarbonate, DIBAL-H=diisobutylalu-
minum hydride, TBS=tert-butyldimethylsilyl, DMF=N,N-dimethylfor-
mamide, TEMPO=2,2,6,6-tetramethyl-1-piperidinyloxy free radical,
NCS=N-chlorosuccinimide, TMEDA=N,N,N’,N’-tetramethylethylene-
diamine.
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2010, 49, 9693 –9698